BIOMAT Database Logo BIOMAT Database Logo

Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's Disease. 2015

Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.

Paget's disease of bone (PDB) is a common disease characterized by osteoclast activation that leads to various skeletal complications. Susceptibility to PDB is mediated by a common variant at the optineurin (OPTN) locus, which is associated with reduced levels of mRNA. However, it is unclear how this leads to the development of PDB. Here, we show that OPTN acts as a negative regulator of osteoclast differentiation in vitro and that mice with a loss-of-function mutation in Optn have increased osteoclast activity and bone turnover. Osteoclasts derived from Optn mutant mice have an increase in NF-κB activation and a reduction in interferon beta expression in response to RANKL when compared to wild-type mice. These studies identify OPTN as a regulator of bone resorption and are consistent with a model whereby genetically determined reductions in OPTN expression predispose to PDB by enhancing osteoclast differentiation.

UI MeSH Term Description Entries
D010001 Osteitis Deformans A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. Paget's Disease of Bone,Osseous Paget's Disease,Paget Disease of Bone,Paget Disease, Bone,Pagets Disease, Bone
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D010012 Osteogenesis The process of bone formation. Histogenesis of bone including ossification. Bone Formation,Ossification, Physiologic,Endochondral Ossification,Ossification,Ossification, Physiological,Osteoclastogenesis,Physiologic Ossification,Endochondral Ossifications,Ossification, Endochondral,Ossifications,Ossifications, Endochondral,Osteoclastogeneses,Physiological Ossification
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005136 Eye Proteins PROTEINS derived from TISSUES of the EYE. Proteins, Eye
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D016899 Interferon-beta One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity. Interferon, Fibroblast,beta-Interferon,Fiblaferon,Interferon, beta,Interferon, beta-1,Interferon-beta1,beta-1 Interferon,Fibroblast Interferon,Interferon beta,Interferon beta1,Interferon, beta 1,beta 1 Interferon,beta Interferon

Related Publications

Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity.
March 2019, Molecular cell,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
RNF4 negatively regulates NF-κB signaling by down-regulating TAB2.
September 2015, FEBS letters,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1.
September 2017, BMB reports,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
September 2019, European journal of pharmacology,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling.
November 2020, JCI insight,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
NF-κB RelB negatively regulates osteoblast differentiation and bone formation.
April 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB Pathway.
August 2018, Molecular and cellular biology,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
Ubiquitin-Specific Protease 34 Inhibits Osteoclast Differentiation by Regulating NF-κB Signaling.
August 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK.
June 2011, Immunity,
Rami Obaid, and Sachin E Wani, and Asim Azfer, and Toby Hurd, and Ruth Jones, and Philip Cohen, and Stuart H Ralston, and Omar M E Albagha
BAT3 negatively regulates lipopolysaccharide-induced NF-κB signaling through TRAF6.
September 2016, Biochemical and biophysical research communications,
Copied contents to your clipboard!